Format

Send to

Choose Destination
See comment in PubMed Commons below
Vaccine. 2006 May 1;24(18):3772-6. Epub 2005 Jul 28.

Intussusception and rotavirus vaccines.

Author information

1
Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital, Murdoch Children's Research Institute, University of Melbourne, Flemington Road, Parkville 3052, Vic., Australia. julie.bines@rch.org.au

Abstract

The association between the first oral rotavirus vaccine to be licensed in the U.S. (Rotashield) and intussusception has presented a major challenge to the effort to reduce the global burden related to rotavirus infection. Although the risk of developing intussusception following immunization with Rotashield is low, debate continues about the estimation of intussusception risk and the events surrounding the withdrawal of the vaccine. The experience with Rotashield has highlighted the wisdom of parallel clinical trials in developing and developed countries and the value of post-licensure surveillance for the detection of uncommon adverse events. This review retraces the steps leading up to the withdrawal of the Rotashield vaccine and reflects on how this experience has influenced the development of other rotavirus vaccines.

PMID:
16099078
DOI:
10.1016/j.vaccine.2005.07.031
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center